NFSG
AVTX icon

Newbridge Financial Services Group’s Avalo Therapeutics AVTX Stock Holding History

Newbridge Financial Services Group’s Portfolio AVTX Stock Details AVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Hold
0
– -$1 – 1158
2023
Q3 		– Hold
0
– – – 1281
2023
Q2 		– Hold
0
– – – 1344
2023
Q1 		– Hold
0
– – – 1396
2022
Q4 		– Hold
0
– – – 1416
2022
Q3 		– Hold
0
– – – 1382
2022
Q2 		– Hold
0
– – – 1362
2022
Q1 		– Hold
0
– – – 1438
2021
Q4 		– Hold
0
– – – 1414
2021
Q3 		– Hold
0
– – – 1224
2021
Q2 		– Hold
0
– – – 1432
2021
Q1 		– Hold
0
– – – 1232
2020
Q4 		– Hold
0
– – – 1005
2020
Q3 		– Hold
0
– – – 1029

Other funds holding AVTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return